Found 6 matching trials
The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)
PHASE1Lymphangioleiomyomatosis (LAM) is a rare lung disease that mostly affects w...
Location
University of Cincinnati
The Tolerability and Effects of AZD0530 in Individuals With or Without a Family History of Alcoholism
PHASE1Functional neuroimaging of alcoholism vulnerability: glutamate, reward, imp...
Location
Hartford Hospital
Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours
PHASE1The purpose of the study is to determine if the maximum tolerated doses of ...
Saracatinib and Alcohol Drinking
PHASE2The purpose of this study is to evaluate the effects of the study medicatio...
Location
CMHC, Substance Abuse Center
Investigating the Interactions of AZD0530 With Alcohol in Social Drinkers
PHASE1The purpose of this alcohol-interaction pilot study is to provide informati...
Location
CMHC, Substance Abuse Center
Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis
PHASE1Scarring of the lung, termed pulmonary fibrosis (PF), is a chronic, progres...
Status
Active Not Recruiting
Location
National Jewish Health